370
Views
0
CrossRef citations to date
0
Altmetric
Article Commentary

Naloxone Prescribing and Education in Outpatient Pain Management and Palliative Care

Pages 100-105 | Received 14 Jan 2020, Accepted 23 Oct 2020, Published online: 12 Apr 2021
 

Abstract

Over the past two decades, opioid use and overdose have increased substantially. Naloxone, an opioid overdose reversal agent, has been one of many risk mitigation strategies for preventing mortality due to overdose. Most literature describing naloxone utilization has been about populations of illicit drug users and patients in hospitals, primary care, and pharmacies. There is limited information regarding naloxone prescribing and training for opioid users in specialty pain management clinics. Furthermore, there are no known publications concerning patients receiving palliative care services and overdose prevention. Pain and palliative care patients are commonly at risk of opioid overdose. In an interdisciplinary outpatient pain and palliative care clinic, pharmacists implemented naloxone prescribing and education. Eleven patients at increased risk for overdose were prescribed naloxone and educated on overdose risk factors, recognition, and management. Seven patients reported picking up their naloxone prescription from the pharmacy, and none reported using it within two weeks of the initial education. This intervention was deemed successful within the clinic, but small sample size and the pharmacist role may not be replicable within other pain and palliative care settings. It encourages further research of overdose risk and prevention in pain management and palliative care.

Acknowledgements

The authors would like to acknowledge Dr. Lan Ly and Cecilia Daskas, PharmD Candidate, for their role implementing this project in clinic, and Drs. Alvin Mathe, Nicholaus Mize, and Nori Watson for their support of the project. The authors would also like to thank Drs. Randy Martin and Cheng Yuet for their comments on the manuscript.

Declaration of interest

The authors have no conflict of interest. The present study was conducted without any external funding or support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.